Ipecacuanha (Carapichea ipecacuanha)
What Is Ipecacuanha?
Botanists and formularies know Ipecacuanha as Carapichea ipecacuanha, a plant of the Rubiaceae family, native to the rainforests of Brazil and Central America. The material in circulation is root — an underground part, harvested once the plant has drawn its reserves down. The common name Ipecacuanha and the botanical name Carapichea ipecacuanha refer to the same material, and labels may use either — a detail that matters when related species in the same genus are not interchangeable. In the hand it reads as bitter, faintly acrid, dusty — a practical marker of freshness and correct identification.
Historically, Ipecacuanha was learned by hand: which stands to harvest, how to dry the root without spoiling it, and how much to use. Those observations were recorded generations before its compounds were named. Beyond its practical use it carries cultural associations — amazonian 'poaya' — vomiting cleanse root.
Today most searches for Ipecacuanha come from people reading about congestion and lung support, or checking how it sits alongside a medication they already take. The use most often documented in the literature is low-dose expectorant in bronchitis (Commission E), followed by historic emetic (no longer recommended for poisoning).
How Does Ipecacuanha Work?
Ipecacuanha is not a single active substance. Its chemistry is a mixture, and the fractions that researchers isolate most often are Alkaloids. Alkaloids is the fraction most often standardised in extracts, associated in the literature with bioactive nitrogen-containing compounds.
Traditional practice described Ipecacuanha in terms of taste, warmth and preparation rather than molecules — a working vocabulary that predicted which extractions were worth making long before any compound was isolated.
The research base is developing: there are human trials, though sample sizes and designs vary, and this profile cites 1 source. Reported findings centre on root: 2-3% isoquinoline alkaloids emetine and cephaeline. Where research exists, it examines low-dose expectorant in bronchitis (Commission E), historic emetic (no longer recommended for poisoning) and amoebicide in acute amoebic dysentery (emetine). These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
The reason Ipecacuanha is treated as its own entry rather than a substitute for a related plant is proportion: related species share several of these compound classes, but not in the same ratio or concentration.
Because these constituents are processed by the same pathways that handle many medicines, Ipecacuanha is documented as interacting with digoxin. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Ipecacuanha can differ substantially; this is why reference entries specify root and, where they exist, standardisation markers.